Deval L. Patrick, Director at Global Blood Therapeutics, Inc. (GBT), bought 2,500 shares at $20.00 ($50K) on 2015-08-17, disclosed to the SEC on 2016-01-07.
Open-market purchase of $50k GBT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CERE | SELL | 2023-11-03 | $753K | — | Filing → |
| CERE | SELL | 2022-09-14 | $2.9M | — | Filing → |
| AMWL | BUY | 2022-04-22 | $198K | — | Filing → |